Trovagene (TROV) Tops Q4 EPS by 1c

Trovagene (NASDAQ: TROV) reported Q4 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Trovagene (TROV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c